期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 56, 期 8, 页码 3121-3147出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm3015926
关键词
-
资金
- National Institutes of Health [GM049725, DA030604]
- Department of Defense [W81XWH-10-1-0536]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049725] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030604] Funding Source: NIH RePORTER
The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown. In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: N-methyl-D-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation. These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade. The synergistic delivery of two or more compounds directed against these targets, along with the design of small molecules with multiple modes of action, should be explored in pursuit of more effective clinical treatments for neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据